Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery - Rebarber, A; Istwan, N B; Russo-Stieglitz, K (Diabetes Care, 2007)
, et al.